April 2, 2018 / 12:38 PM / 8 months ago

BRIEF-Idera Pharma Files Definitive Proxy Statement Over With Pending Merger With Biocryst

April 2 (Reuters) - Idera Pharmaceuticals Inc :

* IDERA PHARMACEUTICALS FILES DEFINITIVE PROXY STATEMENT IN CONNECTION WITH PENDING MERGER WITH BIOCRYST PHARMACEUTICALS

* ‍BOARD OF DIRECTORS RECOMMEND THAT ALL STOCKHOLDERS VOTE "FOR" MERGER PROPOSAL AS WELL AS ALL OTHER IDERA PROPOSALS​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below